Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Gross Margin of 4.64% for Q1 2026, down 97.46% sequentially from 182.84% in Q4 2025, and down 97.0% YoY from 154.54% in Q1 2025.
Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Gross Margin for 7 years, with the latest figure at 4.64% in Q1 2026.
- Quarterly Gross Margin fell 97.0% year-over-year to 4.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 83.95% (up 9376.0% YoY) and the FY2025 annual result came in at 80.47%, up 5548.0% from the prior year.
- Gross Margin slipped to 4.64% in Q1 2026 per RPID's latest filing, from 182.84% in the prior quarter.
- Over five years, Gross Margin peaked at 182.84% in Q4 2025 and troughed at 197.19% in Q4 2022.
- A 5-year average of 19.84% and a median of 25.85% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2025: Gross Margin slumped 26023 bps in 2022, then surged 27172 bps in 2025.
- Over 5 years, Gross Margin stood at 197.19% in 2022, then jumped by 113 bps to 25.85% in 2023, then plunged by 444 bps to 88.88% in 2024, then surged by 306 bps to 182.84% in 2025, then sank by 97 bps to 4.64% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 4.64%, 182.84%, and 29.03% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 45.84% |
| 10 | Rapid Micro Biosystems | 80.50 Mn | 60.73 Mn | 1.21 Mn | 15.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.05% |
| Mar 31, 2026 | 4.64% |
| Dec 31, 2025 | 182.84% |
| Sep 30, 2025 | 29.03% |
| Jun 30, 2025 | 76.98% |
| Mar 31, 2025 | 5.61% |
| Dec 31, 2024 | -88.88% |
| Sep 30, 2024 | 30.12% |
| Jun 30, 2024 | 25.70% |
| Mar 31, 2024 | 7.81% |
| Dec 31, 2023 | 25.85% |
| Sep 30, 2023 | 7.39% |
| Jun 30, 2023 | 55.92% |
| Mar 31, 2023 | 1.07% |
| Dec 31, 2022 | -197.19% |
| Sep 30, 2022 | 59.78% |
| Jun 30, 2022 | 52.18% |
| Mar 31, 2022 | 58.51% |
| Dec 31, 2021 | 63.04% |
| Sep 30, 2021 | 78.03% |